Performant Healthcare Files Proxy Materials

TL;DR

PHC filed more proxy docs, shareholders need to review for voting.

AI Summary

Performant Healthcare, Inc. filed a Definitive Additional Materials proxy statement (DEFA14A) on October 3, 2025. The filing pertains to the company's proxy materials, indicating it is providing supplementary information to shareholders. The company's principal executive offices are located in Plantation, Florida, with a mailing address in Pleasanton, California.

Why It Matters

This filing provides shareholders with additional information related to voting matters, which is crucial for their participation in corporate governance decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing additional materials, not indicating any immediate financial distress or significant corporate event.

Key Players & Entities

• Performant Healthcare, Inc. (company) — Registrant
• 900 SOUTH PINE ISLAND ROAD (address) — Business Address
• PLANTATION (location) — Business Address City
• 4309 HACIENDA DR (address) — Mail Address
• PLEASANTON (location) — Mail Address City

FAQ

Key Financial Figures

• $1.78 — ted an implied value reference range of $1.78 to $2.93 per Company Share based on the
• $2.93 — plied value reference range of $1.78 to $2.93 per Company Share based on the Company'
• $11.8 million — re based on the Company's LTM EBITDA of $11.8 million and $1.94 to $3.27 per Company Share ba
• $1.94 — mpany's LTM EBITDA of $11.8 million and $1.94 to $3.27 per Company Share based on the
• $3.27 — TM EBITDA of $11.8 million and $1.94 to $3.27 per Company Share based on the Company'
• $132.3 million — e based on the Company's LTM Revenue of $132.3 million , in each case as compared to the Merge
• $7.75 — compared to the Merger Consideration of $7.75 per Company Share in the Merger pursuan
• $3.63 — ursuant to the Merger Agreement and the $3.63 closing price per Company Share on July
• $4.26 — ted an implied value reference range of $4.26 to $7.16 per Company Share, as compared
• $7.16 — plied value reference range of $4.26 to $7.16 per Company Share, as compared to the M
• $367 million — range for the Company of approximately $367 million to $617 million. Additionally, solely f
• $617 million — ompany of approximately $367 million to $617 million. Additionally, solely for informational

Filing Documents

• ef20056653_defa14a.htm (DEFA14A) — 27KB
• 0001140361-25-037253.txt ( ) — 28KB

Forward-Looking Statements

Forward-Looking Statements This Supplement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements regarding the following: the anticipated benefits of the proposed Merger, including future plans, objectives, expectations, and intentions; Performant's potential or projected future financial performance and expenditures; and other expectations and estimates or statements which are not historical facts. Forward-looking statements can be identified by terms such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "foresee," "intend," "may," "plan," "project," "should," "will," "would," and the negative of these terms or other similar expressions. These forward-looking statements are based upon information currently available to Performant and are subject to risks, uncertainties, and other factors that could cause actual results to vary materially from those expressed in, or implied by, these forward-looking statements. Important factors that could cause actual results to vary materially from the results referred to in the forward-looking statements in this Supplement include the risks noted in the section entitled "CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS" beginning on page 21 of the Proxy Statement, as well risks related to potential future claims or litigation in connection with the proposed Merger and the potential impact of the same on the timing and ability of the parties to consummate the proposed Merger, and expenses associated with the proposed Merger. For a more detailed description of the risk factors associated with Performant, refer to Performant's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, Performant's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and subsequent SEC filings by

View Full Filing

View this DEFA14A filing on SEC EDGAR